Facultad de Psicología, Universidad Nacional Autónoma de México, Mexico.
Facultad de Psicología, Universidad Nacional Autónoma de México, Mexico.
Epilepsy Behav. 2019 Mar;92:290-296. doi: 10.1016/j.yebeh.2018.12.012. Epub 2019 Feb 4.
For a long time, numerous sleep alterations induced by nocturnal epilepsy have been described. Such alterations include sleep fragmentation, decrement of sleep efficiency, increment of the wake time after sleep onset (WASO), increment of light sleep, and decrement of sleep depth. On the other hand, gabapentin (GBP), an antiepileptic drug analog of γ-aminobutyric acid (GABA) used as adjunctive and eventually, as a monotherapeutic treatment, induces a significant improvement in patients with both focal and secondarily generalized partial seizures. In experimental epilepsy models, this drug protects against pentylenetetrazol (PTZ)-induced convulsions. In consideration of such GBP properties, the aim of this work was to investigate its efficacy to protect against sleep disturbances provoked by convulsive seizures induced by the administration of PTZ. Nine-hour (9-hour) polygraphic studies were carried out in chronically implanted male adult Wistar rats separated into 4 different groups of 6 individuals. Control recordings in each group were done after saline administration. One group received a SC Subcutaneous (SC) injection of 50 mg/kg of PTZ alone while the other three groups were injected with either 15, 30, or 60 mg/kg IP Intraperitoneal (IP) of GBP 30 min prior to PTZ (50 mg/kg SC) administration. Animals displayed the whole range of electrophysiological and behavioral manifestations of the disease during the epileptic episodes induced by PTZ administration, and the states of vigilance were significantly altered. Insomnia occurred immediately after PTZ injection preceding the appearance of the first epileptic symptoms. Thus, both slow wave sleep (SWS) and rapid eye movement sleep (REM sleep) were completely inhibited during a relatively long period of time. The disturbing effects of epilepsy on sleep decreased when animals were under GBP treatment. Improvement of sleep was dependent on the administered dose of this antiepileptic drug.
长期以来,已经描述了许多由夜间癫痫引起的睡眠改变。这些改变包括睡眠碎片化、睡眠效率降低、睡眠潜伏期后觉醒时间增加(WASO)、轻度睡眠增加和深度睡眠减少。另一方面,加巴喷丁(GBP)是γ-氨基丁酸(GABA)的抗癫痫药物类似物,用作辅助治疗,最终作为单药治疗,可显著改善局灶性和继发性全身性部分发作患者的病情。在实验性癫痫模型中,该药物可预防戊四氮(PTZ)诱导的惊厥。考虑到 GBP 的这些特性,本研究旨在研究其预防由 PTZ 给药引起的惊厥性癫痫发作引起的睡眠障碍的功效。在慢性植入的雄性成年 Wistar 大鼠中进行了 9 小时(9 小时)多导睡眠图研究,这些大鼠分为 4 个不同的 6 个个体组。在每组中,在给予生理盐水后进行对照记录。一组单独接受 50mg/kg 的 PTZ 皮下(SC)注射,而另外三组在给予 50mg/kg 的 PTZ 之前 30 分钟分别接受 15、30 或 60mg/kg 的腹腔(IP)GBP 注射。动物在 PTZ 给药引起的癫痫发作期间表现出疾病的全范围电生理和行为表现,警觉状态明显改变。失眠症在出现第一次癫痫症状之前立即在 PTZ 注射后发生。因此,在相对较长的时间内,慢波睡眠(SWS)和快速眼动睡眠(REM 睡眠)完全被抑制。当动物处于 GBP 治疗下时,癫痫对睡眠的干扰作用会降低。睡眠的改善取决于这种抗癫痫药物的给药剂量。